Sharon Forsyth
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Surgery
- Co-authors
- Ivana ŠestakIan S. FentimanSarah E. PinderWilliam D. GeorgeJack CuzickIan O. EllisHugh BishopJohn Forbes
- Topics
- Sarcoma Diagnosis and Treatment (8 papers)Management of metastatic bone disease (8 papers)Cancer Immunotherapy and Biomarkers (4 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteThe Lancet Oncology
- Partner nations
- United KingdomAustraliaAustria
In The Last Decade
Sharon Forsyth
25 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 639
- Pulmonary and Respiratory Medicine 493
- Cancer Research 423
- Pathology and Forensic Medicine 316
- Surgery 242
Countries citing papers authored by Sharon Forsyth
This map shows the geographic impact of Sharon Forsyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Forsyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Forsyth more than expected).
Fields of papers citing papers by Sharon Forsyth
This network shows the impact of papers produced by Sharon Forsyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Forsyth. The network helps show where Sharon Forsyth may publish in the future.
Co-authorship network of co-authors of Sharon Forsyth
This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Forsyth. A scholar is included among the top collaborators of Sharon Forsyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Forsyth. Sharon Forsyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | 2 | |
| 13 | 3 | |
| 14 | Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trialbreakdown → | 340 |
| 15 | 4 | |
| 16 | 26 | |
| 17 | 68 | |
| 18 | 4 | |
| 19 | 372 | |
| 20 | 41 |
About Sharon Forsyth
Sharon Forsyth is a scholar working on Otorhinolaryngology, Oncology and Radiation, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), Management of metastatic bone disease (8 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (423 citations), Oncology (639 citations) and Pathology and Forensic Medicine (316 citations). Sharon Forsyth has collaborated with scholars based in United Kingdom, Australia and Austria. Frequent co-authors include Ivana Šestak, Ian S. Fentiman, Sarah E. Pinder, William D. George, Jack Cuzick, Ian O. Ellis, Hugh Bishop, John Forbes, Nigel Bundred and Jeremy Whelan. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.